Pilot study of bortezomib under rituximab standard therapy in patients with relapsed or refractory follicular lymphoma and at least 2 prior therapies

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2005
This article has no abstract
Epistemonikos ID: 1ac31ef60c0ee7489881451cb55b1e6251b4901f
First added on: Jan 21, 2025